LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Canertinib | 1.11 | uM | LJP6 | 0.3549 | 0.0144 | -0.0767 | 0.0797 |
| SK-BR-3 | Celastrol | 1.11 | uM | LJP6 | 0.3183 | 0.0098 | -0.1356 | 0.0641 |
| SK-BR-3 | CGP60474 | 1.11 | uM | LJP5 | 0.2762 | 0.0292 | -0.2107 | 0.1140 |
| SK-BR-3 | CGP60474 | 1.11 | uM | LJP6 | 0.2381 | 0.0153 | -0.2699 | 0.0794 |
| SK-BR-3 | CHIR-99021 | 1.11 | uM | LJP6 | 0.8344 | 0.0524 | 0.7149 | 0.0979 |
| SK-BR-3 | CP724714 | 1.11 | uM | LJP5 | 0.4891 | 0.0155 | 0.1480 | 0.0572 |
| SK-BR-3 | CP466722 | 1.11 | uM | LJP5 | 0.9827 | 0.0507 | 0.9738 | 0.0865 |
| SK-BR-3 | Crizotinib | 1.11 | uM | LJP5 | 0.7729 | 0.0550 | 0.6243 | 0.0901 |
| SK-BR-3 | Momelotinib | 1.11 | uM | LJP5 | 0.8094 | 0.0423 | 0.6840 | 0.0697 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP5 | 0.8651 | 0.0277 | 0.7759 | 0.0464 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 0.8299 | 0.0242 | 0.7184 | 0.0359 |
| SK-BR-3 | Dovitinib | 1.11 | uM | LJP5 | 0.6701 | 0.0577 | 0.4611 | 0.0622 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 1.0613 | 0.0136 | 1.1026 | 0.0235 |
| SK-BR-3 | Erlotinib | 1.11 | uM | LJP5 | 0.9585 | 0.0298 | 0.9332 | 0.0502 |
| SK-BR-3 | Foretinib | 1.11 | uM | LJP5 | 0.3662 | 0.0120 | -0.0543 | 0.0437 |
| SK-BR-3 | R406 | 1.11 | uM | LJP6 | 1.0552 | 0.0480 | 1.0873 | 0.0814 |
| SK-BR-3 | Pictilisib | 1.11 | uM | LJP6 | 0.4282 | 0.0308 | 0.0463 | 0.0817 |
| SK-BR-3 | Gefitinib | 1.11 | uM | LJP6 | 0.6297 | 0.0147 | 0.3822 | 0.0464 |
| SK-BR-3 | Geldanamycin | 1.11 | uM | LJP5 | 0.3883 | 0.0334 | -0.0137 | 0.0253 |
| SK-BR-3 | Geldanamycin | 1.11 | uM | LJP6 | 0.3745 | 0.0192 | -0.0396 | 0.0410 |
| SK-BR-3 | GSK1059615 | 1.11 | uM | LJP5 | 0.4302 | 0.0162 | 0.0531 | 0.0341 |
| SK-BR-3 | GSK1059615 | 1.11 | uM | LJP6 | 0.3947 | 0.0056 | -0.0096 | 0.0665 |
| SK-BR-3 | GSK1904529A | 1.11 | uM | LJP6 | 0.9689 | 0.0153 | 0.9492 | 0.0255 |
| SK-BR-3 | Omipalisib | 1.11 | uM | LJP6 | 0.2812 | 0.0338 | -0.2003 | 0.1064 |
| SK-BR-3 | GSK 690693 | 1.11 | uM | LJP5 | 0.7330 | 0.0205 | 0.5583 | 0.0177 |